Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 30 05 2021
accepted: 03 08 2021
pubmed: 14 8 2021
medline: 15 12 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

Myotonic disorders are a group of diseases affecting the muscle, in different ways. Myotonic dystrophy type 1 (DM1) is related to (CTG)n expansion in the 3-untranslated region of the dystrophia myotonica protein kinase (DMPK) gene and is the most frequent and disabling form, causing muscular, visibility, respiratory, and cardiac impairment. Non-dystrophic myotonias (NDMs) affect the skeletal muscle alone. In particular, mutations in the chloride channel (CLCN1) gene cause myotonia congenita (MC), which can have autosomal dominant or recessive inheritance. We describe a patient with a family history of asymptomatic or paucisymptomatic myotonia, who presented handgrip myotonia which sharply reduced after mexiletine administration. Molecular analysis showed both a paternally inherited DMPK expansion and a maternally inherited CLCN1 mutation. Only one other similar case was reported so far; however, the segregation of the two mutations and the characteristics of the muscle were not studied. Since our patient lacked the classical phenotypical and muscle histopathological characteristics of DM1 and showed mild splicing alterations despite a pathogenic DMPK expansion and the nuclear accumulation of toxic RNA, we may speculate that the co-occurrence of a CLCN1 mutation could have attenuated the severity of DM1 phenotype.

Identifiants

pubmed: 34386887
doi: 10.1007/s10072-021-05538-y
pii: 10.1007/s10072-021-05538-y
doi:

Substances chimiques

Chloride Channels 0
DMPK protein, human 0
Myotonin-Protein Kinase EC 2.7.11.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5365-5368

Informations de copyright

© 2021. Fondazione Società Italiana di Neurologia.

Références

Tan SV, Z’Graggen WJ, Boërio D, Rayan DR et al (2014) Chloride channels in myotonia congenita assessed by velocity recovery cycles. Muscle Nerve 49(6):845–857. https://doi.org/10.1002/mus.24069
doi: 10.1002/mus.24069 pubmed: 24037712
Fialho D, Schorge S, Pucovska U et al (2007) Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 130(Pt 12):3265–3274. https://doi.org/10.1093/brain/awm248
doi: 10.1093/brain/awm248 pubmed: 17932099
Wang K, Preisler SS, Zhang L et al (2019) Structure of the human ClC-1 chloride channel. PLoS Biol 17(4):e3000218. https://doi.org/10.1371/journal.pbio.3000218
doi: 10.1371/journal.pbio.3000218 pubmed: 31022181 pmcid: 6483157
Vihola A, Bassez G, Meola G et al (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60:1854–1857. https://doi.org/10.1212/01.wnl.0000065898.61358.09
doi: 10.1212/01.wnl.0000065898.61358.09 pubmed: 12796551
Suominen T, Schoser B, Raheem O et al (2008) High frequency of cosegregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol 255:1731–1736. https://doi.org/10.1007/s00415-008-0010-z
doi: 10.1007/s00415-008-0010-z pubmed: 18807109 pmcid: 4079033
Kassardjian C, Milone M (2014) Coexistence of DMPK gene expansion and CLCN1 missense mutation in the same patient. Neurogenetics 15:213–214. https://doi.org/10.1007/s10048-014-0402-4
doi: 10.1007/s10048-014-0402-4 pubmed: 24705798
Lueck JD, Lungu C, Mankodi A et al (2007) Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 292:C1291-1297. https://doi.org/10.1152/ajpcell.00336.2006
doi: 10.1152/ajpcell.00336.2006 pubmed: 17135300

Auteurs

Sara Locci (S)

Department of Medical, Surgical and Neurological Sciences, Unit of Neurology and Neurometabolic Diseases, University of Siena, Siena, Italy.

Rosanna Cardani (R)

Laboratory of Muscle Histopathology and Molecular Biology, IRCCS Policlinico San Donato, Milan, Italy.

Paola Brunori (P)

Unit of Neurophysiopathology, Silvestrini Hospital, Perugia, Italy.

Sabrina Lucchiari (S)

Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Giacomo P Comi (GP)

Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Antonio Federico (A)

Department of Medical, Surgical and Neurological Sciences, Unit of Neurology and Neurometabolic Diseases, University of Siena, Siena, Italy.

Nicola De Stefano (N)

Department of Medical, Surgical and Neurological Sciences, Unit of Neurology and Neurometabolic Diseases, University of Siena, Siena, Italy.

Giovanni Meola (G)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan, Italy.

Andrea Mignarri (A)

Department of Medical, Surgical and Neurological Sciences, Unit of Neurology and Neurometabolic Diseases, University of Siena, Siena, Italy. andrea.mignarri@teletu.it.
Department of Medicine, Surgery and Neurosciences, University of Siena, Viale Bracci 2, 53100, Siena, Italy. andrea.mignarri@teletu.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH